Description
Seeking adults whose triple-negative breast cancer remained following surgery and pre-surgery treatment for a study of an investigational drug.
Overview
Participants in this study will get either the investigational drug combination or the usual treatment recommended by their doctor. The drugs will be given as IV infusions on 21-day cycles for 8 cycles.
What we're hoping for
We are studying if an investigational drug combination is better, worse or the same as the usual treatment for triple negative breast cancer that still remains in the breast or lymph node tissue after receiving treatment and undergoing surgery.
Additional Information
ClinicalTrials.gov Identifier: NCT05633654